Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer

This study has been withdrawn prior to enrollment.
(Sponsor withdrew due to funding issues)
Sponsor:
Collaborator:
CTI BioPharma
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01227408
First received: January 8, 2009
Last updated: April 29, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2011
  Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)